Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 27, 2026, Charles J. Dockendorff informed Haemonetics Corporation (the "Company") that he will not stand for re-election at the Company's 2026 Annual Meeting of Shareholders (the "2026 Annual Meeting"). Mr. Dockendorff has served as a member of the Board of Directors (the "Board") of the Company since 2014 and currently serves as a member of the Audit Committee and the Governance and Compliance Committee. Mr. Dockendorff will continue to serve as a director and in his committee roles until the 2026 Annual Meeting. Mr. Dockendorff's decision not to stand for re-election at the 2026 Annual Meeting is not the result of any disagreement with the Company.